Adobe

STAT+ | Merck to buy lung-disease biotech Verona Pharma for $10 billion

The centerpiece of the acquisition is Ohtuvayre, a treatment for chronic obstructive pulmonary disease that secured U.S. approval last year.

By Adam Feuerstein

STAT+ | FDA publishes rejection letters sent to drugmakers, with a big caveat

FDA's Marty Makary says release of rejection letters will help drugmakers and investors understand decisions behind denials. But there's a big caveat.

By Andrew Joseph and Lizzy Lawrence